Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Clinical Trial Supply Exclusive Survey Results Unveiled

on

  • 920 views

Pharma IQ’s Clinical Trial Supply survey delved into ten key areas such as these to find out more about the main challenges you face. Don't miss a chance to learn what the consensus of your industry ...

Pharma IQ’s Clinical Trial Supply survey delved into ten key areas such as these to find out more about the main challenges you face. Don't miss a chance to learn what the consensus of your industry is in these survey findings. Download the full results below...some were surprising, but you spoke and we listened!

Statistics

Views

Total Views
920
Views on SlideShare
920
Embed Views
0

Actions

Likes
0
Downloads
15
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Clinical Trial Supply Exclusive Survey Results Unveiled Clinical Trial Supply Exclusive Survey Results Unveiled Presentation Transcript

  • Pharma IQ’s Clinical Trial Supply Europe Survey Results www.clinicalsupplyeurope.com This survey was conducted with key members of the Clinical Trial Supply area to gain an insight into how professionals are investing in Clinical Trial Supply, the regions they are operating in and their top priorities for 2010-11.
  • www.clinicalsupplyeurope.com H o w ma ny y e a rs ha v e y o u b e e n wo rk ing in the Clinic a l T ria l S up p lie s a re a ? 19% 24% 1-5 6-10 11 -15 16+ 24% 33%
  • www.clinicalsupplyeurope.com W ha t is y o ur numb e r 1 p rio rity a re a fo r 2011? 5% 5% 18% Cost cutting Overage cuts Supporting numerous new trials Supporting current trials 9% Working specifically for trials in emerging markets Other (providing excellent 63% customer service)
  • www.clinicalsupplyeurope.com W hic h a re a s a re y o u lo o k ing to inv e s t in fo r 2011? 50% 43% 40% 33% 30% 24% 24% 19% 20% 14% 10% 5% 0% Supply network for new Comparator trials Other (please specify) emerging markets technologies/outsourcing Greener supply chain Cool chain technologies Supply chains in Packaging and labelling clinical trial/s Other areas include investing in Asia, forecasting systems and all of the above. N.B. Participants chose multiple options
  • www.clinicalsupplyeurope.com A p p ro xima te ly ho w ma ny a c tiv e tria ls d o e s y o ur c o mp a ny run a y e a r? 10% 10% 1-10 11-20 21-30 31-40 41-50 50+ 56% 24%
  • www.clinicalsupplyeurope.com Of the s e , ho w ma ny o f the s e will b e in B R IC c o untrie s in 2011? 19% 29% 5 or less 6-10 11-15 16+ 14% 38%
  • www.clinicalsupplyeurope.com W hic h a re a s a re p ro v ing to b e the mo s t d iffic ult to s hip to ? 60% 52% 50% 40% 29% 30% 20% 14% 10% 10% 5% 0% Russia and the India China Latin America Other (please Ukraine specify)
  • www.clinicalsupplyeurope.com W hic h a s p e c ts o f the Clinic a l T ria l S up p ly func tio n in y o ur c o mp a ny is o uts o urc e d ? 50% 48% 45% 43% 40% 35% 29% 29% 30% 24% 25% 20% 15% 10% 5% 0% Manufacture Packaging and Logistics Distribution Other (please labelling specify) Other: Depot services, part of co-ordination, IVRS and all of the above N.B. Participants chose multiple options
  • www.clinicalsupplyeurope.com H o w ma ny 3rd p a rty p a rtne rs d o y o u wo rk with in the CT S s p a c e ? 19% 5% 5 or less 47% 6-10 11-15 16+ 29%
  • www.clinicalsupplyeurope.com W ha t is y o ur p rima ry mo tiv a tio n fo r o uts o urc ing ? 14% 33% Cost cutting Lack of internal experience/capabilities Other (please specify) 53% Other: Lack of local presence in other continents, lack of resource flexibility and under developed IVRS technology.
  • www.clinicalsupplyeurope.com Clinical Trial Supply Europe Dates: 26 - 28 January, 2011 Venue: World Trade Centre, Rotterdam, The Netherlands Innovative techniques for effective clinical supply planning, packaging and distribution to cut costs and speed time to market In response to industry demand, Pharma IQ’s Clinical Trial Supply Europe conference will bring together senior industry experts from across the globe to discuss innovative approaches to planning, packaging, distribution, comparator sourcing and much more in three days of interactive presentations and discussions. The 30 Clinical Trial experts will be sharing their expertise on: •Maintaining compliance with the evolving GxP regulatory landscape •Ensuring product viability of temperature controlled clinical materials •Guaranteeing uninterrupted supply in emerging markets such as Eastern Europe and Latin America PLUS! Don't miss: 1. 8+ hours of dedicated networking including an Evening Drinks Reception and Gala Dinner 2. Two tailored streams 3. Exclusive to Pharma IQ: Interactive Crisis Management Session For more information or to register: Tel: +44 207 368 9300 Email: enquire@iqpc.co.uk Visit: http://www.clinicalsupplyeurope.com